nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—CYP2B6—malignant glioma	0.8	1	CbGaD
Raloxifene—Deep vein thrombosis—Temozolomide—malignant glioma	0.0026	0.0425	CcSEcCtD
Raloxifene—Embolism—Temozolomide—malignant glioma	0.00246	0.0403	CcSEcCtD
Raloxifene—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00214	0.0349	CcSEcCtD
Raloxifene—Breast pain—Temozolomide—malignant glioma	0.00181	0.0296	CcSEcCtD
Raloxifene—Pulmonary embolism—Carmustine—malignant glioma	0.00164	0.0268	CcSEcCtD
Raloxifene—Vaginal inflammation—Temozolomide—malignant glioma	0.00158	0.0259	CcSEcCtD
Raloxifene—Pulmonary embolism—Temozolomide—malignant glioma	0.00158	0.0259	CcSEcCtD
Raloxifene—Vaginal infection—Temozolomide—malignant glioma	0.00149	0.0244	CcSEcCtD
Raloxifene—Diabetes mellitus—Carmustine—malignant glioma	0.00136	0.0223	CcSEcCtD
Raloxifene—Gastroenteritis—Temozolomide—malignant glioma	0.00129	0.0212	CcSEcCtD
Raloxifene—Hot flush—Temozolomide—malignant glioma	0.00123	0.0201	CcSEcCtD
Raloxifene—Menopausal symptoms—Temozolomide—malignant glioma	0.00122	0.0199	CcSEcCtD
Raloxifene—Breast disorder—Temozolomide—malignant glioma	0.00104	0.017	CcSEcCtD
Raloxifene—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00103	0.0169	CcSEcCtD
Raloxifene—Bronchitis—Temozolomide—malignant glioma	0.000954	0.0156	CcSEcCtD
Raloxifene—Pneumonia—Carmustine—malignant glioma	0.00092	0.0151	CcSEcCtD
Raloxifene—Depression—Carmustine—malignant glioma	0.000912	0.0149	CcSEcCtD
Raloxifene—Weight increased—Temozolomide—malignant glioma	0.000902	0.0148	CcSEcCtD
Raloxifene—Urinary tract infection—Carmustine—malignant glioma	0.000889	0.0145	CcSEcCtD
Raloxifene—Pneumonia—Temozolomide—malignant glioma	0.000889	0.0145	CcSEcCtD
Raloxifene—Depression—Temozolomide—malignant glioma	0.000882	0.0144	CcSEcCtD
Raloxifene—Urinary tract infection—Temozolomide—malignant glioma	0.000859	0.0141	CcSEcCtD
Raloxifene—Sinusitis—Temozolomide—malignant glioma	0.000829	0.0136	CcSEcCtD
Raloxifene—Hypoaesthesia—Carmustine—malignant glioma	0.000817	0.0134	CcSEcCtD
Raloxifene—Oedema peripheral—Carmustine—malignant glioma	0.000809	0.0132	CcSEcCtD
Raloxifene—Connective tissue disorder—Carmustine—malignant glioma	0.000807	0.0132	CcSEcCtD
Raloxifene—Hypoaesthesia—Temozolomide—malignant glioma	0.00079	0.0129	CcSEcCtD
Raloxifene—Pharyngitis—Temozolomide—malignant glioma	0.000788	0.0129	CcSEcCtD
Raloxifene—Urinary tract disorder—Temozolomide—malignant glioma	0.000784	0.0128	CcSEcCtD
Raloxifene—Oedema peripheral—Temozolomide—malignant glioma	0.000782	0.0128	CcSEcCtD
Raloxifene—Connective tissue disorder—Temozolomide—malignant glioma	0.00078	0.0128	CcSEcCtD
Raloxifene—Urethral disorder—Temozolomide—malignant glioma	0.000778	0.0127	CcSEcCtD
Raloxifene—Flushing—Carmustine—malignant glioma	0.000762	0.0125	CcSEcCtD
Raloxifene—Flushing—Temozolomide—malignant glioma	0.000737	0.012	CcSEcCtD
Raloxifene—Cardiac disorder—Temozolomide—malignant glioma	0.000737	0.012	CcSEcCtD
Raloxifene—Angiopathy—Temozolomide—malignant glioma	0.00072	0.0118	CcSEcCtD
Raloxifene—Vertigo—Temozolomide—malignant glioma	0.000621	0.0102	CcSEcCtD
Raloxifene—HTR6—telencephalon—malignant glioma	0.000609	0.0751	CbGeAlD
Raloxifene—Chest pain—Carmustine—malignant glioma	0.000609	0.00996	CcSEcCtD
Raloxifene—Myalgia—Carmustine—malignant glioma	0.000609	0.00996	CcSEcCtD
Raloxifene—ESR1—blood vessel—malignant glioma	0.000603	0.0745	CbGeAlD
Raloxifene—Cough—Temozolomide—malignant glioma	0.000603	0.00986	CcSEcCtD
Raloxifene—Arthralgia—Temozolomide—malignant glioma	0.000588	0.00962	CcSEcCtD
Raloxifene—Myalgia—Temozolomide—malignant glioma	0.000588	0.00962	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000584	0.00956	CcSEcCtD
Raloxifene—Infection—Carmustine—malignant glioma	0.00058	0.00948	CcSEcCtD
Raloxifene—Thrombocytopenia—Carmustine—malignant glioma	0.000571	0.00935	CcSEcCtD
Raloxifene—Infection—Temozolomide—malignant glioma	0.00056	0.00916	CcSEcCtD
Raloxifene—Nervous system disorder—Temozolomide—malignant glioma	0.000553	0.00905	CcSEcCtD
Raloxifene—Thrombocytopenia—Temozolomide—malignant glioma	0.000552	0.00903	CcSEcCtD
Raloxifene—Skin disorder—Temozolomide—malignant glioma	0.000548	0.00896	CcSEcCtD
Raloxifene—Hyperhidrosis—Temozolomide—malignant glioma	0.000545	0.00892	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000532	0.0087	CcSEcCtD
Raloxifene—Insomnia—Carmustine—malignant glioma	0.000528	0.00863	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000514	0.0084	CcSEcCtD
Raloxifene—Insomnia—Temozolomide—malignant glioma	0.00051	0.00834	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Carmustine—malignant glioma	0.000504	0.00824	CcSEcCtD
Raloxifene—Pain—Carmustine—malignant glioma	0.000499	0.00816	CcSEcCtD
Raloxifene—Dyspepsia—Temozolomide—malignant glioma	0.000496	0.00812	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000487	0.00796	CcSEcCtD
Raloxifene—Pain—Temozolomide—malignant glioma	0.000482	0.00789	CcSEcCtD
Raloxifene—ESR2—brainstem—malignant glioma	0.000482	0.0595	CbGeAlD
Raloxifene—Gastrointestinal pain—Carmustine—malignant glioma	0.000477	0.0078	CcSEcCtD
Raloxifene—Abdominal pain—Carmustine—malignant glioma	0.000461	0.00755	CcSEcCtD
Raloxifene—Body temperature increased—Carmustine—malignant glioma	0.000461	0.00755	CcSEcCtD
Raloxifene—Gastrointestinal pain—Temozolomide—malignant glioma	0.000461	0.00754	CcSEcCtD
Raloxifene—Abdominal pain—Temozolomide—malignant glioma	0.000446	0.00729	CcSEcCtD
Raloxifene—Body temperature increased—Temozolomide—malignant glioma	0.000446	0.00729	CcSEcCtD
Raloxifene—ESR2—telencephalon—malignant glioma	0.000427	0.0528	CbGeAlD
Raloxifene—Diarrhoea—Carmustine—malignant glioma	0.000399	0.00653	CcSEcCtD
Raloxifene—Dizziness—Carmustine—malignant glioma	0.000386	0.00631	CcSEcCtD
Raloxifene—Diarrhoea—Temozolomide—malignant glioma	0.000386	0.00631	CcSEcCtD
Raloxifene—Dizziness—Temozolomide—malignant glioma	0.000373	0.0061	CcSEcCtD
Raloxifene—Vomiting—Carmustine—malignant glioma	0.000371	0.00607	CcSEcCtD
Raloxifene—Rash—Carmustine—malignant glioma	0.000368	0.00602	CcSEcCtD
Raloxifene—Dermatitis—Carmustine—malignant glioma	0.000368	0.00601	CcSEcCtD
Raloxifene—Headache—Carmustine—malignant glioma	0.000366	0.00598	CcSEcCtD
Raloxifene—ESR1—embryo—malignant glioma	0.00036	0.0444	CbGeAlD
Raloxifene—Vomiting—Temozolomide—malignant glioma	0.000359	0.00586	CcSEcCtD
Raloxifene—Rash—Temozolomide—malignant glioma	0.000356	0.00582	CcSEcCtD
Raloxifene—Dermatitis—Temozolomide—malignant glioma	0.000355	0.00581	CcSEcCtD
Raloxifene—Headache—Temozolomide—malignant glioma	0.000353	0.00578	CcSEcCtD
Raloxifene—Nausea—Carmustine—malignant glioma	0.000347	0.00567	CcSEcCtD
Raloxifene—HTR6—central nervous system—malignant glioma	0.000346	0.0427	CbGeAlD
Raloxifene—Nausea—Temozolomide—malignant glioma	0.000335	0.00548	CcSEcCtD
Raloxifene—SIGMAR1—telencephalon—malignant glioma	0.000331	0.0409	CbGeAlD
Raloxifene—HTR2B—telencephalon—malignant glioma	0.00033	0.0408	CbGeAlD
Raloxifene—ESR1—brainstem—malignant glioma	0.00033	0.0407	CbGeAlD
Raloxifene—ESR1—telencephalon—malignant glioma	0.000293	0.0361	CbGeAlD
Raloxifene—HTR6—brain—malignant glioma	0.000275	0.0339	CbGeAlD
Raloxifene—SIGMAR1—medulla oblongata—malignant glioma	0.00026	0.0321	CbGeAlD
Raloxifene—ESR2—central nervous system—malignant glioma	0.000243	0.03	CbGeAlD
Raloxifene—SIGMAR1—midbrain—malignant glioma	0.000238	0.0294	CbGeAlD
Raloxifene—ESR2—cerebellum—malignant glioma	0.000237	0.0293	CbGeAlD
Raloxifene—SIGMAR1—spinal cord—malignant glioma	0.000232	0.0286	CbGeAlD
Raloxifene—AOX1—cerebellum—malignant glioma	0.000229	0.0282	CbGeAlD
Raloxifene—ESR2—brain—malignant glioma	0.000193	0.0238	CbGeAlD
Raloxifene—CYP19A1—central nervous system—malignant glioma	0.000191	0.0236	CbGeAlD
Raloxifene—HTR2B—central nervous system—malignant glioma	0.000188	0.0232	CbGeAlD
Raloxifene—AOX1—brain—malignant glioma	0.000186	0.0229	CbGeAlD
Raloxifene—SIGMAR1—cerebellum—malignant glioma	0.000184	0.0227	CbGeAlD
Raloxifene—ESR1—central nervous system—malignant glioma	0.000166	0.0205	CbGeAlD
Raloxifene—ESR1—cerebellum—malignant glioma	0.000163	0.0201	CbGeAlD
Raloxifene—CYP19A1—brain—malignant glioma	0.000152	0.0188	CbGeAlD
Raloxifene—SIGMAR1—brain—malignant glioma	0.000149	0.0184	CbGeAlD
Raloxifene—HTR2B—brain—malignant glioma	0.000149	0.0184	CbGeAlD
Raloxifene—ESR1—brain—malignant glioma	0.000132	0.0163	CbGeAlD
Raloxifene—CYP2B6—central nervous system—malignant glioma	0.000123	0.0152	CbGeAlD
Raloxifene—CYP2C8—brain—malignant glioma	0.000109	0.0134	CbGeAlD
Raloxifene—CYP2B6—brain—malignant glioma	9.76e-05	0.0121	CbGeAlD
Raloxifene—CYP3A4—central nervous system—malignant glioma	9.29e-05	0.0115	CbGeAlD
Raloxifene—ESR1—Signaling Pathways—NOTCH3—malignant glioma	2.32e-05	0.000178	CbGpPWpGaD
Raloxifene—AOX1—Disease—STAT3—malignant glioma	2.31e-05	0.000177	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GSTT1—malignant glioma	2.29e-05	0.000176	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PTK2—malignant glioma	2.29e-05	0.000175	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FBXW7—malignant glioma	2.29e-05	0.000175	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CXCL8—malignant glioma	2.28e-05	0.000175	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—NCOR1—malignant glioma	2.27e-05	0.000174	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.26e-05	0.000173	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PIK3CD—malignant glioma	2.25e-05	0.000173	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HES1—malignant glioma	2.25e-05	0.000172	CbGpPWpGaD
Raloxifene—EBP—Metabolism—AKT1—malignant glioma	2.24e-05	0.000172	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—BDKRB2—malignant glioma	2.24e-05	0.000172	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NCOR1—malignant glioma	2.24e-05	0.000171	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—MYC—malignant glioma	2.22e-05	0.00017	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—RAF1—malignant glioma	2.2e-05	0.000169	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—IL2—malignant glioma	2.18e-05	0.000167	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MMP3—malignant glioma	2.17e-05	0.000166	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—PIK3CB—malignant glioma	2.16e-05	0.000166	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PTEN—malignant glioma	2.16e-05	0.000166	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—PIK3CB—malignant glioma	2.15e-05	0.000165	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CDKN2B—malignant glioma	2.15e-05	0.000165	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PTGS1—malignant glioma	2.14e-05	0.000164	CbGpPWpGaD
Raloxifene—AOX1—Disease—MYC—malignant glioma	2.14e-05	0.000164	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PDGFRA—malignant glioma	2.14e-05	0.000164	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—MYC—malignant glioma	2.12e-05	0.000162	CbGpPWpGaD
Raloxifene—AOX1—Disease—EGFR—malignant glioma	2.09e-05	0.000161	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PTK2—malignant glioma	2.09e-05	0.00016	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NOTCH2—malignant glioma	2.08e-05	0.00016	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ASMT—malignant glioma	2.08e-05	0.00016	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—CXCL8—malignant glioma	2.08e-05	0.000159	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SPP1—malignant glioma	2.08e-05	0.000159	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CXCL8—malignant glioma	2.07e-05	0.000159	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.06e-05	0.000158	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HES1—malignant glioma	2.05e-05	0.000157	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NCOR1—malignant glioma	2.04e-05	0.000156	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—KNG1—malignant glioma	2.04e-05	0.000156	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—RAF1—malignant glioma	2.01e-05	0.000154	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—BCHE—malignant glioma	1.99e-05	0.000153	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—IL2—malignant glioma	1.99e-05	0.000152	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.99e-05	0.000152	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—NOTCH1—malignant glioma	1.98e-05	0.000152	CbGpPWpGaD
Raloxifene—AOX1—Disease—KRAS—malignant glioma	1.98e-05	0.000152	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL2—malignant glioma	1.98e-05	0.000152	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TERT—malignant glioma	1.97e-05	0.000151	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.97e-05	0.000151	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PIK3CB—malignant glioma	1.97e-05	0.000151	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—BCAN—malignant glioma	1.96e-05	0.00015	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PDGFRA—malignant glioma	1.95e-05	0.00015	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NTRK1—malignant glioma	1.94e-05	0.000149	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GSTT1—malignant glioma	1.94e-05	0.000149	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PDGFB—malignant glioma	1.92e-05	0.000147	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FGFR1—malignant glioma	1.91e-05	0.000147	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SPP1—malignant glioma	1.9e-05	0.000145	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CXCL8—malignant glioma	1.89e-05	0.000145	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HIF1A—malignant glioma	1.88e-05	0.000144	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—PPARG—malignant glioma	1.87e-05	0.000144	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CAV1—malignant glioma	1.85e-05	0.000142	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CAV1—malignant glioma	1.82e-05	0.00014	CbGpPWpGaD
Raloxifene—AOX1—Disease—PIK3CA—malignant glioma	1.82e-05	0.000139	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PTGS1—malignant glioma	1.82e-05	0.000139	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.81e-05	0.000139	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MMP3—malignant glioma	1.81e-05	0.000139	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL2—malignant glioma	1.8e-05	0.000138	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—KDR—malignant glioma	1.8e-05	0.000138	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TERT—malignant glioma	1.8e-05	0.000138	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CDKN2B—malignant glioma	1.79e-05	0.000137	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.77e-05	0.000136	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PDGFB—malignant glioma	1.75e-05	0.000135	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FGFR1—malignant glioma	1.75e-05	0.000134	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PTK2—malignant glioma	1.74e-05	0.000133	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—F2—malignant glioma	1.73e-05	0.000133	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FN1—malignant glioma	1.73e-05	0.000133	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HIF1A—malignant glioma	1.72e-05	0.000132	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—BAD—malignant glioma	1.71e-05	0.000131	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HES1—malignant glioma	1.71e-05	0.000131	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NCOR1—malignant glioma	1.7e-05	0.00013	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NOTCH1—malignant glioma	1.7e-05	0.00013	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—BCHE—malignant glioma	1.69e-05	0.000129	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PIK3CG—malignant glioma	1.69e-05	0.000129	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—SLC5A5—malignant glioma	1.67e-05	0.000128	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CAV1—malignant glioma	1.66e-05	0.000128	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CD80—malignant glioma	1.66e-05	0.000127	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—APC—malignant glioma	1.66e-05	0.000127	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PIK3CG—malignant glioma	1.66e-05	0.000127	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—KDR—malignant glioma	1.64e-05	0.000126	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—EGF—malignant glioma	1.64e-05	0.000126	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PTPN11—malignant glioma	1.63e-05	0.000125	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PDGFRA—malignant glioma	1.63e-05	0.000125	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PPARG—malignant glioma	1.63e-05	0.000125	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GSTP1—malignant glioma	1.59e-05	0.000122	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—F2—malignant glioma	1.58e-05	0.000121	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FN1—malignant glioma	1.58e-05	0.000121	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SPP1—malignant glioma	1.58e-05	0.000121	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—IDH2—malignant glioma	1.58e-05	0.000121	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.58e-05	0.000121	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—BAD—malignant glioma	1.56e-05	0.00012	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.56e-05	0.00012	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—BRAF—malignant glioma	1.56e-05	0.00012	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NOTCH1—malignant glioma	1.55e-05	0.000119	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CAT—malignant glioma	1.54e-05	0.000118	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PIK3CA—malignant glioma	1.52e-05	0.000117	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—AKT2—malignant glioma	1.52e-05	0.000116	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CD80—malignant glioma	1.52e-05	0.000116	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—APC—malignant glioma	1.51e-05	0.000116	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PIK3CG—malignant glioma	1.51e-05	0.000116	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—EGFR—malignant glioma	1.51e-05	0.000116	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TERT—malignant glioma	1.5e-05	0.000115	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—EGF—malignant glioma	1.5e-05	0.000115	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PTPN11—malignant glioma	1.49e-05	0.000114	CbGpPWpGaD
Raloxifene—AOX1—Disease—AKT1—malignant glioma	1.49e-05	0.000114	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.48e-05	0.000114	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PIK3CD—malignant glioma	1.48e-05	0.000114	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—AKT1—malignant glioma	1.47e-05	0.000113	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PDGFB—malignant glioma	1.46e-05	0.000112	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PIK3CD—malignant glioma	1.46e-05	0.000112	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—NCOR1—malignant glioma	1.46e-05	0.000112	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FGFR1—malignant glioma	1.45e-05	0.000112	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—PIK3CA—malignant glioma	1.45e-05	0.000111	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HIF1A—malignant glioma	1.43e-05	0.00011	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—KRAS—malignant glioma	1.43e-05	0.00011	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—BRAF—malignant glioma	1.42e-05	0.000109	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FGF2—malignant glioma	1.4e-05	0.000107	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AKT2—malignant glioma	1.39e-05	0.000106	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CAV1—malignant glioma	1.39e-05	0.000106	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—EGFR—malignant glioma	1.38e-05	0.000106	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—KDR—malignant glioma	1.37e-05	0.000105	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.36e-05	0.000104	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—IDH1—malignant glioma	1.36e-05	0.000104	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GSTP1—malignant glioma	1.34e-05	0.000103	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PIK3CD—malignant glioma	1.33e-05	0.000102	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—PIK3CA—malignant glioma	1.32e-05	0.000101	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—F2—malignant glioma	1.32e-05	0.000101	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FN1—malignant glioma	1.32e-05	0.000101	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SPHK1—malignant glioma	1.31e-05	0.000101	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—PIK3CA—malignant glioma	1.31e-05	0.000101	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CAT—malignant glioma	1.31e-05	0.0001	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MDM2—malignant glioma	1.31e-05	0.0001	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—KRAS—malignant glioma	1.3e-05	0.0001	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—BAD—malignant glioma	1.3e-05	9.99e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—RAF1—malignant glioma	1.3e-05	9.99e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PIK3CB—malignant glioma	1.29e-05	9.9e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NOTCH1—malignant glioma	1.29e-05	9.89e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ERBB2—malignant glioma	1.29e-05	9.88e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.29e-05	9.86e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PTGS2—malignant glioma	1.28e-05	9.81e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FGF2—malignant glioma	1.28e-05	9.78e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PIK3CB—malignant glioma	1.27e-05	9.75e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CD80—malignant glioma	1.26e-05	9.69e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PIK3CG—malignant glioma	1.26e-05	9.68e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—APC—malignant glioma	1.26e-05	9.68e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—EGF—malignant glioma	1.25e-05	9.56e-05	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—AKT1—malignant glioma	1.24e-05	9.54e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PTPN11—malignant glioma	1.24e-05	9.51e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—NCOR1—malignant glioma	1.23e-05	9.46e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CXCL8—malignant glioma	1.22e-05	9.37e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PIK3CA—malignant glioma	1.2e-05	9.19e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MDM2—malignant glioma	1.19e-05	9.15e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—RAF1—malignant glioma	1.19e-05	9.12e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CAV1—malignant glioma	1.19e-05	9.11e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—BRAF—malignant glioma	1.19e-05	9.1e-05	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—AKT1—malignant glioma	1.18e-05	9.05e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ERBB2—malignant glioma	1.18e-05	9.02e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CASP3—malignant glioma	1.17e-05	8.97e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL2—malignant glioma	1.17e-05	8.96e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PIK3CB—malignant glioma	1.16e-05	8.9e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AKT2—malignant glioma	1.15e-05	8.85e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PTEN—malignant glioma	1.12e-05	8.56e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CXCL8—malignant glioma	1.12e-05	8.55e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PIK3CD—malignant glioma	1.11e-05	8.51e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MMP9—malignant glioma	1.11e-05	8.48e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PTEN—malignant glioma	1.1e-05	8.43e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PIK3CG—malignant glioma	1.08e-05	8.3e-05	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—AKT1—malignant glioma	1.08e-05	8.26e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—AKT1—malignant glioma	1.07e-05	8.22e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—MYC—malignant glioma	1.07e-05	8.19e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CASP3—malignant glioma	1.07e-05	8.19e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL2—malignant glioma	1.07e-05	8.17e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FGF2—malignant glioma	1.06e-05	8.14e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PPARG—malignant glioma	1.04e-05	8.01e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTT1—malignant glioma	1.04e-05	7.98e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MMP9—malignant glioma	1.01e-05	7.74e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CAV1—malignant glioma	1.01e-05	7.72e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PTEN—malignant glioma	1e-05	7.69e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MDM2—malignant glioma	9.94e-06	7.62e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—VEGFA—malignant glioma	9.93e-06	7.61e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RAF1—malignant glioma	9.9e-06	7.59e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—STAT3—malignant glioma	9.83e-06	7.54e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ERBB2—malignant glioma	9.8e-06	7.51e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—AKT1—malignant glioma	9.79e-06	7.5e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PTGS1—malignant glioma	9.75e-06	7.47e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PIK3CB—malignant glioma	9.67e-06	7.41e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.61e-06	7.37e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PIK3CD—malignant glioma	9.52e-06	7.3e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CXCL8—malignant glioma	9.29e-06	7.13e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PIK3CG—malignant glioma	9.17e-06	7.03e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MYC—malignant glioma	9.13e-06	7e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—BCHE—malignant glioma	9.06e-06	6.95e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—VEGFA—malignant glioma	9.06e-06	6.95e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—STAT3—malignant glioma	8.97e-06	6.88e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SLC5A5—malignant glioma	8.95e-06	6.86e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—EGFR—malignant glioma	8.93e-06	6.85e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CASP3—malignant glioma	8.89e-06	6.82e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL2—malignant glioma	8.88e-06	6.81e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PPARG—malignant glioma	8.85e-06	6.78e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—KRAS—malignant glioma	8.44e-06	6.47e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MMP9—malignant glioma	8.4e-06	6.44e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PTEN—malignant glioma	8.36e-06	6.41e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MYC—malignant glioma	8.34e-06	6.39e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PIK3CB—malignant glioma	8.3e-06	6.36e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PTGS2—malignant glioma	8.22e-06	6.3e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—EGFR—malignant glioma	8.15e-06	6.25e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PIK3CD—malignant glioma	8.06e-06	6.18e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PIK3CA—malignant glioma	7.87e-06	6.04e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PIK3CA—malignant glioma	7.75e-06	5.94e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—KRAS—malignant glioma	7.7e-06	5.91e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—VEGFA—malignant glioma	7.55e-06	5.79e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TP53—malignant glioma	7.5e-06	5.75e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—STAT3—malignant glioma	7.47e-06	5.73e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—AKT1—malignant glioma	7.41e-06	5.68e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTP1—malignant glioma	7.21e-06	5.53e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PTEN—malignant glioma	7.17e-06	5.5e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	7.08e-06	5.43e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PIK3CB—malignant glioma	7.02e-06	5.39e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CAT—malignant glioma	7.02e-06	5.38e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PTGS2—malignant glioma	6.96e-06	5.34e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MYC—malignant glioma	6.94e-06	5.32e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TP53—malignant glioma	6.85e-06	5.25e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—EGFR—malignant glioma	6.79e-06	5.21e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NCOR1—malignant glioma	6.63e-06	5.08e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—AKT1—malignant glioma	6.43e-06	4.93e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—KRAS—malignant glioma	6.42e-06	4.92e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—AKT1—malignant glioma	6.33e-06	4.86e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PTEN—malignant glioma	6.07e-06	4.65e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PIK3CA—malignant glioma	5.89e-06	4.52e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AKT1—malignant glioma	5.78e-06	4.43e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TP53—malignant glioma	5.7e-06	4.37e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CAV1—malignant glioma	5.4e-06	4.14e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PIK3CA—malignant glioma	5.06e-06	3.88e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PIK3CG—malignant glioma	4.92e-06	3.77e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AKT1—malignant glioma	4.82e-06	3.69e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PPARG—malignant glioma	4.75e-06	3.64e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.32e-06	3.32e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PIK3CA—malignant glioma	4.28e-06	3.28e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—AKT1—malignant glioma	4.13e-06	3.17e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.77e-06	2.89e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PTGS2—malignant glioma	3.74e-06	2.86e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—AKT1—malignant glioma	3.5e-06	2.68e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PTEN—malignant glioma	3.26e-06	2.5e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.3e-06	1.76e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AKT1—malignant glioma	1.88e-06	1.44e-05	CbGpPWpGaD
